EMAMILTD Q3 FY25 Concall Summary & Key Takeaways (EMAMILTD)

EMAMILTD Q3 FY25 (Dec-2024 Qtr) Earnings call highlights: Key takeaways, performance, financial metrics, outlook and guidance, concerns and management tone.

Emami Ltd (EMAMILTD) Q3FY25 Concall Summary - Dec-2024 Qtr

Performance Overview

  • Emami Ltd. reported a robust core domestic business growth of 8.6% with a volume growth of around 6% in Q3 FY24.
  • This growth was achieved despite challenges in male grooming (down 4%) and Kesh King (down 10%).
  • BoroPlus range performed exceptionally well, growing by 20% driven by antiseptic cream sales.
  • Healthcare range saw 13% growth, led by Zandu Care's 90% growth. Navratna and Pain Management portfolios grew by 3% each.
  • Consolidated revenue for Q3 FY24 stood at INR 1,049 crores, a 5% increase, after accounting for a 13% decline in strategic investments and a 3% decline in international business.
  • Fair and Handsome was rebranded to Smart and Handsome, aiming to expand the brand's reach in the male grooming market.
  • Mentho Plus Balm Total was launched in the southern region.
  • Organized channels (modern trade, e-commerce, institutional sales) contributed 28.6% of domestic business, growing at nearly double the pace of the overall domestic business.
  • Gross margins expanded by 150 basis points to 70.3%.
  • EBITDA grew by 8% to INR 339 crores, with margins expanding by 70 basis points.
  • Profit after tax increased by 8% to INR 279 crores.
  • For the nine months ended December '24:
  • Gross margins expanded by 140 basis points to 69.6%.
  • EBITDA grew by 9% to INR 806 crores.
  • PAT increased by 12% to INR 644 crores.
  • The Board declared a second interim dividend of 400% (INR 4 per share), totaling 800% (INR 8 per share) for FY24.
  • Core domestic business delivered 7% growth, including 5% volume growth, for the nine months ended December '24.

Financial Metrics

Log in to Stocksigma to read the Financial Metrics section of this summary.

Operating Performance / Business Segments

Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.

Key Discussions & Insights

Log in to Stocksigma to read the Key Discussions & Insights section of this summary.

Outlook and Guidance

Log in to Stocksigma to read the Outlook and Guidance section of this summary.

Challenges / Concerns

Log in to Stocksigma to read the Challenges / Concerns section of this summary.

Industry / Competitive Landscape

Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.

Overall Summary

Log in to Stocksigma to read the Overall Summary section of this summary.